|
TSEN15 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.952200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.720200E-01 |
| Normal-vs-Stage2 |
5.268200E-01 |
| Normal-vs-Stage3 |
5.824800E-01 |
| Normal-vs-Stage4 |
4.207000E-01 |
| Stage1-vs-Stage2 |
9.529000E-01 |
| Stage1-vs-Stage3 |
1.012220E-01 |
| Stage1-vs-Stage4 |
1.105960E-01 |
| Stage2-vs-Stage3 |
2.947400E-01 |
| Stage2-vs-Stage4 |
2.306200E-01 |
| Stage3-vs-Stage4 |
7.422200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.932200E-01 |
| Normal-vs-AfricanAmerican |
5.125600E-01 |
| Normal-vs-Asian |
2.994800E-01 |
| Caucasian-vs-AfricanAmerican |
4.514600E-01 |
| Caucasian-vs-Asian |
3.115400E-01 |
| AfricanAmerican-vs-Asian |
9.902200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.372800E-01 |
| Normal-vs-Female |
5.053600E-01 |
| Male-vs-Female |
5.713200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.704400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.473000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.500200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.808600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.426970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.520200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.964800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.989000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.516600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.731800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.369800E-01 |
| Classical-VS-Follicular |
5.758400E-01 |
| Classical-VS-Other |
3.319800E-01 |
| Classical-VS-Normal |
3.186200E-01 |
| Tall-VS-Follicular |
8.359200E-01 |
| Tall-VS-Other |
4.900200E-01 |
| Tall-VS-Normal |
9.806600E-01 |
| Follicular-VS-Other |
4.914200E-01 |
| Follicular-VS-Normal |
7.853600E-01 |
| Other-VS-Normal |
3.710800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.099200E-01 |
| Normal-vs-N1 |
8.520800E-01 |
| N0-vs-N1 |
9.855400E-01 |
|
|
